Systemic inflammation following infection is usually associated with long-term complications
including cognitive deficit and dementia. Neuroinflammation and cognitive decline are also …

Alzheimer's disease is the most common major neurocognitive disorder with substantial
social and economic impacts. This article is an update on current pharmacotherapy …

Sulfur is widely existent in natural products and synthetic organic compounds as
organosulfur, which are often associated with a multitude of biological activities …

Recently, the significantly higher incidence of Alzheimer's disease (AD) in women than in
men has been attributed to the loss of neuroprotective estrogen after menopause. Does …

The lengthy and expensive process of developing new drugs from scratch, coupled with a
high failure rate, has prompted the emergence of drug repurposing/repositioning as a more …

Alzheimer's disease (AD) is a serious multifactorial disorder with progressive
neurodegenerative outcomes related with impaired redox homeostasis. Inhibition of the …

Background Despite several hundred clinical trials of drugs that initially showed promise,
there has been limited clinical improvement in Alzheimer's disease (AD). This may be …

Alzheimer's disease (AD) is a progressive neurodegenerative disease and the most
common cause of dementia in the elderly. Up to date, the available pharmacological options …

Abstract Alzheimer's disease (AD), a relentless neurodegenerative disorder, is still waiting
for safer profile drugs, risk factors affecting AD's pathogenesis include aβ accumulation, tau …

Inflammation is a common hallmark of neurodegenerative disorders. Systemic inflammation
is usually associated with cognitive deficits. Scutellarin is a flavone with established …